Brain Metastases: Whole-Brain Radiation Therapy Perspective

  • Roy A. Patchell
  • William F. Regine


Whole-brain radiation therapy (WBRT) is the mainstay of treatment for most patients with intracerebral metastases. It is useful for most newly diagnosed tumors and sometimes also as salvage therapy for recurrent tumors.


Brain Metastasis Radiat Oncol Biol Phys Radiation Therapy Oncology Group Stereotactic Radiosurgery Multiple Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Berk L. An overview of radiotherapy trials for the treatment of brain metastases. Oncology 1995; 9:1205–1219.PubMedGoogle Scholar
  2. 2.
    Posner JB. Management of brain metastases. Rev Neurol 1992; 148:477–487.PubMedGoogle Scholar
  3. 3.
    Cairncross JG, Posner JB. The management of brain metastases. In: Walker MD, ed. Oncology of the Nervous System. Boston: Martinus Nijhoff, 1983:341–377.Google Scholar
  4. 4.
    Horton J, Baxter DH, Olson KB. The management of metastases to the brain by irradiation and corticosteroids. Am J Roentgenol Radium Ther Nucl Med 1971; 111:334–335.PubMedGoogle Scholar
  5. 5.
    Markesbery WR, Brooks WH, Gupta GD, et al. Treatment for patients with cerebral metastases. Arch Neurol 1978; 35:754–756.PubMedGoogle Scholar
  6. 6.
    Ruderman NB, Hall TC. Use of glucocorticoids in the palliative treatment of metastatic brain tumors. Cancer 1965; 18:298–306.CrossRefPubMedGoogle Scholar
  7. 7.
    Chang DB, Yang PC, Luh KT, et al. Late survival of non-small cell lung cancer patients with brain metastases. Chest 1992; 101:1293–1297.CrossRefPubMedGoogle Scholar
  8. 8.
    Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980; 6:1–9.PubMedGoogle Scholar
  9. 9.
    Gelber RD, Larson M, Borgelt BB, et al. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 1981; 48:1749–1753.CrossRefPubMedGoogle Scholar
  10. 10.
    Kurtz JM, Gelber RD, Brady LW, et al. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981; 7:891–895.PubMedGoogle Scholar
  11. 11.
    Deiner-West M, Dobbins TW, Phillips TL, et al. Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 1989; 16:669–673.Google Scholar
  12. 12.
    Epstein BE, Scott CB, Sause WT, et al. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of the Radiation Therapy Oncology Group 85-28. Cancer 1993; 7:1362–1367.CrossRefGoogle Scholar
  13. 13.
    Murray KJ, Scott C, Greenberg H, et al. A randomized phase III study of accelerated hyperfractionated versus standard radiation in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997; 39:571–574.PubMedGoogle Scholar
  14. 14.
    Hoskins PJ, Crow J, Ford HT. The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 1990; 19:111–115.Google Scholar
  15. 15.
    Eyre HJ, Ohlsen JD, Frank J, et al. Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to the brain. J Neuro-Oncology 1984; 2:325–330.Google Scholar
  16. 16.
    Komarnicky LT, Phillips TL, Martz K, et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991; 20:53–58.PubMedGoogle Scholar
  17. 17.
    Mehta MP, Rodrigus P, Terhaard CH, et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 2003; 21:2529–2536.CrossRefPubMedGoogle Scholar
  18. 18.
    Suh JH, Stea B, Nabid A, et al. Phase III study of efaproxiral as an adjunct to whole brain radiation therapy for brain metastases. J Clin Oncol 2006; 24:106–114.CrossRefPubMedGoogle Scholar
  19. 19.
    DeAngelis LM, Mandell LR, Thaler HT, et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery 1989; 24:798–805.CrossRefPubMedGoogle Scholar
  20. 20.
    Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999; 45:427–434.PubMedGoogle Scholar
  21. 21.
    Chougule PB, Burton-Williams M, Saris S, et al. Randomized treatment of brain metastases with gamma knife radiosurgery, whole brain radiotherapy or both. Int J Radiat Oncol Biol Phys 2000; 48:114.Google Scholar
  22. 22.
    Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with and without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 2004; 363:1665–1672.CrossRefPubMedGoogle Scholar
  23. 23.
    Elveen T, Andrews DW. Summary of RTOG 95-01 phase III randomized trial of whole brain radiation with and without stereotactic radiosurgery boost, including presentation of a clinical case study. Am J Oncol Rev 2004; 3:592–600.Google Scholar
  24. 24.
    Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998; 280:1485–1489.CrossRefPubMedGoogle Scholar
  25. 25.
    Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs Stereotactic radiosurgery alone for the treatment of brain metastases. JAMA 2006; 295:2483–2491.CrossRefPubMedGoogle Scholar
  26. 26.
    Raizer J. Radiosurgery and whole-brain radiation therapy for brain metastases. JAMA 2006; 295:2535–2536.CrossRefPubMedGoogle Scholar
  27. 27.
    Regine WF, Scott C, Murray K, Curran W. Neurocognitive outcome in brain metastases patients treated with accelera tedfraction vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 2001; 51:711–717.PubMedGoogle Scholar
  28. 28.
    Regine WF, Huhn JL, Patchell RA, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery al in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys 2002; 52:333–338.PubMedGoogle Scholar
  29. 29.
    Taylor BV, Buckner JC, Cascino TL, et al. Effects of radiation and chemotherapy on cognitive function in patients with highgrade gliomas. J Clin Oncol 1998; 16:2195–2201.PubMedGoogle Scholar
  30. 30.
    Hocht S, Wiegel T, Hinkelbein W. Reirradiation for recurrent brain metastases. Controversies in Neuro-Oncology. Front Radiat Oncol Basal 1999; 33:327–331.CrossRefGoogle Scholar
  31. 31.
    Hazuka MB, Kinzie JJ. Brain metastases: results and effects of reirradiation. Int J Radiat Oncol Biol Phys 1988; 15:433–437.PubMedGoogle Scholar
  32. 32.
    Kurup P, Reddy S, Hendrickson FR. Results of re-irradiation for cerebral metastases. Cancer 1980; 46:2587–2589.CrossRefPubMedGoogle Scholar
  33. 33.
    Wong WW, Schild SE, Sawyer TE, et al. Analysis of outcome in patients reirradiated for brain metastases. Int J Rad Oncol Biol Phys 1996; 34:585–590.Google Scholar
  34. 34.
    Cooper JS, Steinfeld AD, Lerch IA. Cerebral metastases: value of reirradiation in selected patients. Radiology 1990; 174:883–885.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Roy A. Patchell
    • 1
  • William F. Regine
    • 2
  1. 1.University of Kentucky Medical CenterLexingtonUSA
  2. 2.Department of Radiation OncologyUniversity of Maryland Medical SchoolBaltimoreUSA

Personalised recommendations